• Print
  • Bookmark and Share
  • RSS Feeds Feeds

Shands Hospital at the University of Florida

Bone Marrow Transplant Program
1600 Southwest Archer Road
Box 100403
Gainesville, FL 32610-0403
Direct phone: (352) 265-0062
Toll-free phone: (800) 749-7424
http://www.shands.org/find/service/bonemarrowtx.asp

Program Description:

  More than 2,000 allogeneic, autologous and unrelated transplants have been performed at the Blood and Bone Marrow Transplant Program at Shands at the University of Florida, established in 1981. Our multidisciplinary team works together to evaluate each patient and determine the best course of treatment.

Contact Information:

  If you have transplant-related questions, please contact Tiffany Rouillier, transplant center coordinator, at (352) 733-0972 (ext. 2-9482) or by e-mail at rouilt@shands.ufl.edu.

Program Type:

  Adult (ages 18 to 75) and Pediatric (ages 0 to 25)

Attending Physicians:

(Medical Doctors)
 

Adult -

Randy Brown, Christopher Cogle, Jack Hsu, W. Stratford May, Jan Moreb, John Wingard, Baldeep Wirk

Pediatric -

Levette Dunbar, Vishwas Sakhalkar, William Slayton, Amy Smith

Transplants Performed:

  Marrow/PBSC, single cord, and double cord

Cord blood transplants performed on:

  Adult and pediatric

Mismatches allowed:

For marrow, PBSC, or cord blood transplant with an unrelated donor. Match criteria may vary based on patient's age, disease type and stage.
 
Marrow/PBSC Cord Blood
Number: One Two
Location: Any locus A or B antigen and DRB1 allele or antigen
helpExplain Transplant Center HLA Match Requirements

Estimated Search & Transplant Costs

Costs vary greatly from center to center, and depend on factors such as health insurance, disease type, and disease stage of the patient, as well as center-specific billing policies.
Activation of formal search$1,155 - 3,069
DR testing of A/B tested donors (per donor)$479 - 1,485
Confirmatory typing blood sample (per sample)$528 - 2,310
IDM sample collection/testing (per donor)$330 - 3,762
High resolution - HLA typing$330 - 4,500
Marrow or PBSC procurement$40,293 - 68,062
Cord blood procurement (including shipping fees)$16,286 - 73,161
Cord blood typing$230 - 2,200

The costs listed above are only a small part of the total cost of a transplant. Contact your transplant center to learn more about costs of actual transplant and follow-up treatment.

helpExplain Transplant Costs at Different Centers

Financial Services:

Financial services at this center could include:

  • Health insurance information
  • Financial assistance
  • Patient-related resources

Resources for financial information

If you have questions about costs and financial services at this transplant center, you can contact the center's financial representative, Debbie Rechsteiner at (352) 265-0062 or by e-mail at rechsd@shands.ufl.edu.

Many organizations exist to help patients with lodging, transportation and other transplant-related expenses. Visit the National Marrow Donor Program's Patient Organizations database for more information. Financial assistance resources are also listed on this Web site.

Transplant Experience

This center has been performing allogeneic transplants since 1981 and has been an NMDP transplant center since October 1988.

Transplants Performed

(Using NMDP and non-NMDP donors from Jan. 2003 to Dec. 2007 as reported by the centers)

Marrow

PBSC

Cord
Blood

Auto-
logous

Total

(by transplant type)

Total Non-
Myeloblative transplants*

Unrelated Donor - Adult 29 55 14 --- 98 31
Unrelated Donor - Pediatric 10 10 40 --- 60 6
Related Donor - Adult 7 107 0 --- 114 34
Related Donor - Pediatric 22 13 5 --- 40 0
Autologous (PBSC and Marrow) - Adult --- --- --- 327 327 ---
Autologous (PBSC and Marrow) - Pediatric --- --- --- 104 104 ---
Total (by cell source) 68 185 59 431 743 71

This center performed a total of 149 transplants, all types, in the most recent year (from June 2008 to May 2009)

*The total Non-Myeloblative transplants column shows a subset of the total number of transplants by type.

To locate centers that perform cord blood transplants, use the search tool on this site.

The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center.

helpExplain Transplant Experience

Center-Specific Analysis (Using unrelated NMDP donors)

This analysis is based on transplants performed from Jan. 1, 2003 through Dec. 31, 2007, using unrelated NMDP donors. It only includes patients who were confirmed to be either alive or deceased within one year of transplant.
  1. This center reported survival status data for 104 patients.
  2. The overall disease condition of patients treated at this center was in the medium-high risk category (4 on a scale of 1 to 5).
  3. The observed one-year survival of these patients was 53%.
  4. The predicted one-year survival was 55% (with a 95% confidence limit that the predicted survival was between 46% and 64%).
  5. This center's observed results are similar to the predicted range for this center. The estimated national one-year survival was 56.3% in the 9,673 patients transplanted in the United States.

For help with understanding these statistics, please see How to Understand NMDP Transplant Center Statistics.

Survival by Patient's Age, Disease Type and Stage (Using unrelated NMDP donors)


This data is only based on unrelated transplants performed from Jan. 2003 to Dec. 2007. It also includes one year post-transplant follow-up, through Dec. 2008. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.

Key:
CP = chronic phase (1st or 2nd) BP = blastic phase
AP = accelerated phase CR = complete remission (1st, 2nd, 3rd or more)
RLPS = relapse PIF = primary induction failure

Diagnoses

0-10
Yrs

11-17
Yrs

18-30
Yrs

31-40
Yrs

41-50
Yrs

51-60
Yrs

> 60
Yrs

Overall

Acute Bilineage Leukemia -- -- 1/1 -- -- -- -- 1/1
Acute Lymphoblastic Leukemia 1CR -- -- -- 3/4 1/2 1/1 -- 5/7
Acute Lymphoblastic Leukemia 2CR 1/1 -- 2/2 -- 0/1 -- -- 3/4
Acute Lymphoblastic Leukemia 3+CR 3/4 1/2 -- -- 0/1 0/1 -- 4/8
Acute Lymphoblastic Leukemia RLPS -- -- -- 0/1 -- -- -- 0/1
Acute Myelogenous Leukemia 1CR 2/3 -- 3/3 3/4 2/3 4/9 2/4 16/26
Acute Myelogenous Leukemia 2CR 1/1 1/1 1/1 -- 1/2 0/1 1/2 5/8
Acute Myelogenous Leukemia 3+CR/RLPS 0/1 0/1 -- 2/3 0/1 1/1 -- 3/7
Acute Myelogenous Leukemia PIF -- 1/1 -- -- -- 1/1 0/1 2/3
Acute Undifferentiated Leukemia 1/1 -- -- -- -- -- -- 1/1
Chronic Granulomatous Disease 1/1 -- -- -- -- -- -- 1/1
Chronic Lymphocytic Leukemia -- -- -- -- -- 1/2 -- 1/2
Chronic Myelogenous Leukemia 1CP -- 0/1 -- 1/1 -- -- -- 1/2
Chronic Myelogenous Leukemia 2CP -- -- 1/1 1/1 -- 1/1 -- 3/3
Familial Erythrophagocytic Lymphohistiocytosis 0/1 -- -- -- -- -- -- 0/1
Fanconi Anemia 1/1 -- -- -- -- -- -- 1/1
Hodgkin's Disease -- -- 1/1 1/1 0/1 -- -- 2/3
MDS-Myelodysplastic Disorder - Any Type -- -- -- -- -- -- 0/1 0/1
MDS-Other Myelodysplastic Disorder 1/1 0/1 -- -- 0/1 -- 0/1 1/4
MDS-Refractory Anemia -- -- -- 0/1 -- 0/1 -- 0/2
MDS-Refractory Anemia-Excess Blasts -- 0/1 -- 0/1 1/2 -- 0/1 1/5
MDS-Refractory Anemia-Excess Blasts in Transformation -- -- -- -- 0/1 -- -- 0/1
Multiple Myeloma -- -- -- -- -- 0/1 -- 0/1
Myelofibro Myeloid Metaplasia -- -- -- 0/1 -- 1/1 -- 1/2
Non-Hodgkin's Lymphoma -- 0/1 -- -- 1/2 -- -- 1/3
Other Leukemia -- -- -- -- 0/1 -- -- 0/1
Renal Cell Carcinoma 0/1 -- -- -- -- -- -- 0/1
Severe Aplastic Anemia -- 1/1 -- 1/1 0/1 -- -- 2/3
Wiskott-Aldrich Syndrome -- 1/1 -- -- -- -- -- 1/1
Total 11/16 5/11 9/9 12/19 6/19 10/20 3/10 56/104

helpExplain Survival by Patient Diagnosis and Age


Additional Information
Further information about this center, including the number and type of transplants performed in each of the last three years, and the support groups offered, may be found in the BMT InfoNet Transplant Center Directory: http://www.bmtinfonet.org/transplantcenters.

BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.